Free Trial

MorphoSys (MOR) SEC Filings & 10K Form

MorphoSys logo
$18.96 0.00 (0.00%)
As of 03/28/2025

Recent MorphoSys SEC Filings

DateFilerForm TypeView
10/17/2024
3:54 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 15-12G
10/04/2024
3:21 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:24 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:27 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:30 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:33 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:36 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:18 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8 POS
10/04/2024
3:16 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form POSASR
08/27/2024
9:14 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
08/13/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/07/2024
3:51 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
08/07/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/05/2024
7:14 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/01/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/31/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/30/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/29/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/25/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/25/2024
3:05 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
07/18/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/18/2024
10:25 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2024
3:20 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/05/2024
5:48 AM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9
07/05/2024
5:02 AM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T
07/02/2024
9:18 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/21/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
3:41 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
3:33 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
06/20/2024
2:38 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-C
06/17/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/10/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/10/2024
11:06 AM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G/A
06/10/2024
10:01 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2024
3:36 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2024
9:22 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
New “Trump” currency proposed in DC (Ad)

After a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out first. Warren Buffett sold off 115 million shares of Apple last year.

We’ve posted the full recording online, where you can view it free of charge, here.
06/04/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
9:16 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
9:13 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
1:19 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
05/23/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
8:04 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/17/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
3:43 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
05/16/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/16/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
9:27 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2024
9:31 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
3:45 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/07/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/06/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/02/2024
9:43 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
7:57 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
3:15 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/25/2024
9:38 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
10:03 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2024
9:14 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
9:32 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/18/2024
1:33 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D
04/18/2024
9:13 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2024
3:49 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
04/17/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
4:07 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
9:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
2:44 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/12/2024
9:54 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
10:57 AM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9
04/11/2024
5:01 AM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T
04/09/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Crypto Genius: 12,000% in 12 months? [Here’s how] (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
04/02/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:MOR) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners